Navigate / search

Featured Investment Ideas

  • PropThink’s Weekly Biotech Round-Up
    By Editorial Staff · Fri, May 17

    Cell therapy developers Athersys and Cytomedix target the immense stroke treatment market. Mr. Napodano laid out the theses for these two stem cell developers, although he’s more bullish on CMXI for the time being. News this week that Trius had patented a tidezolid/daptomycin combination has an · more »

Latest News


Most Popular



View our Most Popular Posts »